Sign in

CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company

Evofem Biosciences, Inc.

Sign in to watch
Ticker
EVFM
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208527075
Phone
(858) 550-1900
Business address
12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
Former names
Neothetics, Inc.
  1. 4 Shares withheld for taxes Chief Commercial Officer gave up 20,381 shares (to pay taxes)
  2. SC 13G/A Stake Amended Statement of Ownership
  3. 4 Open-market buy Director bought 5,250 shares at $2.99 ($15,698)
  4. 4/A Open-market buy Director bought 5,000 shares at $2.85 ($14,250)
  5. 8-K Event Shareholder vote results
  6. 4 Open-market buy Director bought 5,000 shares at $2.85 ($14,250)
  7. 4 Open-market buy Director bought 5,000 shares at $2.94 ($14,700)
  8. 4 Open-market buy Chief Financial Officer bought 8,500 shares at $3.14 ($26,690)
  9. 4 Open-market sale 10% owner sold 9,138,504 shares at $3.21 ($29,325,459)
  10. 3 Insider Initial Statement of Ownership
  11. SC 13G Stake Amended Statement of Ownership
  12. 8-K Event New debt or obligation · Unregistered share sale
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13D/A Stake Beneficial Ownership Report
  15. 4 Open-market buy 10% owner bought 857,143 shares at $3.50 ($3,000,001)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 42,810 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Medical Officer gave up 31,548 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Executive Officer gave up 85,620 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Commercial Officer gave up 15,455 shares (to pay taxes)
  20. 4 Shares withheld for taxes General Counsel and Secretary gave up 31,590 shares (to pay taxes)

Page 17 of 41 · 802 filings